# Fate Therapeutics Inc: Form 8-K, filed Jan 5, 2023

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: 8-K
- Filed: 2023-01-05
- Accepted by EDGAR: Jan 5, 2023, 17:04 ET
- Period: 2023-01-03
- Accession: 0001193125-23-002504
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000119312523002504/d418503d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000119312523002504/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000119312523002504/d418503d8k.htm

Filed Jan 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-002504. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
